RE: How long till we know if ‘it works’™1 Apr 2026 08:56
And unlike the AVA6000 trial it's not just safety and tolerability.
"We look forward to rapidly gathering data from patients in the FOCUS-01 trial, which is designed to determine the kinetics of payload release, pharmacodynamics, safety and preliminary efficacy of AVA6103."